Porter D, Lahti-Domenici J, Torres-Arzayus M, Chin L, Polyak K (June 2002). "Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues". Mechanisms of Development. 114 (1–2): 201–4. doi:10.1016/S0925-4773(02)00056-4. PMID12175512. S2CID1770009.
Reynolds SD, Reynolds PR, Pryhuber GS, Finder JD, Stripp BR (December 2002). "Secretoglobins SCGB3A1 and SCGB3A2 define secretory cell subsets in mouse and human airways". American Journal of Respiratory and Critical Care Medicine. 166 (11): 1498–509. doi:10.1164/rccm.200204-285OC. PMID12406855.
Krop I, Maguire P, Lahti-Domenici J, Lodeiro G, Richardson A, Johannsdottir HK, Nevanlinna H, Borg A, Gelman R, Barkardottir RB, Lindblom A, Polyak K (May 2003). "Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors". Cancer Research. 63 (9): 2024–7. PMID12727813.
Tisserand P, Fouquet C, Barrois M, Gallou C, Dendale R, Stoppa-Lyonnet D, Sastre-Garau X, Fourquet A, Soussi T (2004). "Lack of HIN-1 methylation defines specific breast tumor subtypes including medullary carcinoma of the breast and BRCA1-linked tumors". Cancer Biology & Therapy. 2 (5): 559–63. doi:10.4161/cbt.2.5.511. PMID14614327. S2CID25141850.
Yang Q, Kiernan CM, Tian Y, Salwen HR, Chlenski A, Brumback BA, London WB, Cohn SL (June 2007). "Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome". Clinical Cancer Research. 13 (11): 3191–7. doi:10.1158/1078-0432.CCR-06-2846. PMID17545522. S2CID13614534.